drugset / Trial / NCT00071942

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

NCT00071942 ↗

Phase 1 Terminated 22 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Vaccines may make the body build an immune response to kill tumor cells. This phase I trial is studying the side effects and best dose of vaccine therapy in treating patients with metastatic breast cancer.

Timeline

Start
2003-10
Primary completion
2007-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject recombinant vaccinia-MUC1 vaccine Vaccine — Other
Subject recombinant vaccinia-TRICOM vaccine Vaccine — Other

Indications